Changli Wang

737 total citations
31 papers, 454 citations indexed

About

Changli Wang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Changli Wang has authored 31 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Changli Wang's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Changli Wang is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Changli Wang collaborates with scholars based in China, United States and Malaysia. Changli Wang's co-authors include Xiang Wu, Qinghua Zhou, Yunde Liu, Ke Xu, Boning Liu, Bin Liu, Yanjun Su, Rui Jia, Zhenfa Zhang and Leina Sun and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Changli Wang

28 papers receiving 452 citations

Peers

Changli Wang
Yujiao Zou China
Sushmaa Chandralekha Selvakumar India
Yuxiang Qiu China
Yuting Kuang China
Francesca Maria Orlandella Italy
Cecilia Bica Romania
Xianling Feng China
Yujiao Zou China
Changli Wang
Citations per year, relative to Changli Wang Changli Wang (= 1×) peers Yujiao Zou

Countries citing papers authored by Changli Wang

Since Specialization
Citations

This map shows the geographic impact of Changli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changli Wang more than expected).

Fields of papers citing papers by Changli Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changli Wang. The network helps show where Changli Wang may publish in the future.

Co-authorship network of co-authors of Changli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Changli Wang. A scholar is included among the top collaborators of Changli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changli Wang. Changli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Huang, et al.. (2025). Cell death signaling and immune regulation: new perspectives on targeted therapy for sepsis. Cellular & Molecular Biology Letters. 30(1). 99–99.
3.
Wang, Changli, et al.. (2025). Dual effects and balanced regulation of cytokines in sepsis. Trends in Immunology. 46(12). 762–765. 1 indexed citations
4.
Wu, Yufei, et al.. (2024). BAP31 Promotes Angiogenesis via Galectin-3 Upregulation in Neuroblastoma. International Journal of Molecular Sciences. 25(5). 2946–2946. 5 indexed citations
5.
Wang, Syu‐Siang, et al.. (2024). Theta/beta ratio in EEG correlated with attentional capacity assessed by Conners Continuous Performance Test in children with ADHD. Frontiers in Psychiatry. 14. 1305397–1305397. 6 indexed citations
6.
Zhang, Qiang, Yu Zhang, Leina Sun, et al.. (2024). Injectable hydrogel with doxorubicin-loaded ZIF-8 nanoparticles for tumor postoperative treatments and wound repair. Scientific Reports. 14(1). 9983–9983. 25 indexed citations
7.
Li, Na, Yi Gong, Bo Li, et al.. (2024). Exogenous acetate attenuates inflammatory responses through HIF-1α-dependent glycolysis regulation in macrophage. Cellular and Molecular Life Sciences. 82(1). 21–21. 8 indexed citations
8.
Wang, Changli, et al.. (2024). A novel arginine methylation-associated lncRNA signature effectively predicts prognosis in breast cancer patients. Frontiers in Oncology. 14. 1472434–1472434. 1 indexed citations
9.
Hu, Yutao, et al.. (2024). A trimmed-NURBS-based thermal buckling isogeometric analysis framework for the variable stiffness plate with complex cutouts. Advances in Engineering Software. 199. 103803–103803. 1 indexed citations
10.
Liu, Jingjing, et al.. (2023). Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer. International Journal of Molecular Sciences. 24(18). 14402–14402. 5 indexed citations
11.
Liu, Jingjing, Qi Zhang, Changli Wang, et al.. (2023). Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin. International Journal of Molecular Sciences. 24(8). 7622–7622. 2 indexed citations
12.
13.
Wang, Changli, Yan Liu, Yan Li, et al.. (2022). Deficiency of microRNA-10b promotes DSS-induced inflammatory response via impairing intestinal barrier function. Biochemical and Biophysical Research Communications. 636(Pt 2). 48–54. 4 indexed citations
14.
Yuan, Jie, Hua Zhang, Zhenfa Zhang, et al.. (2022). Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma. Frontiers in Oncology. 12. 931209–931209. 3 indexed citations
15.
Yue, Dongsheng, Weiran Liu, Liuwei Gao, et al.. (2021). Integrated Multiomics Analyses Revealing Different Molecular Profiles Between Early- and Late-Stage Lung Adenocarcinoma. Frontiers in Oncology. 11. 746943–746943. 7 indexed citations
16.
Jia, Rui & Changli Wang. (2020). <p>MiR-29b-3p Reverses Cisplatin Resistance by Targeting COL1A1 in Non-Small-Cell Lung Cancer A549/DDP Cells</p>. Cancer Management and Research. Volume 12. 2559–2566. 23 indexed citations
17.
Zhang, Yu, Qiang Zhang, Hui Chen, & Changli Wang. (2018). BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway. Life Sciences. 208. 284–294. 22 indexed citations
18.
Chen, Yulong, et al.. (2014). Alternative method for jejunostomy in Ivor‐Lewis esophagectomy. Thoracic Cancer. 6(3). 296–302. 3 indexed citations
19.
Liu, Boning, Xiang Wu, Bin Liu, et al.. (2012). MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(11). 1692–1704. 160 indexed citations
20.
Wang, Changli. (2008). Study and Prospect of EMS Induction on Wheat Mutants. Anhui nongye kexue. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yujiao Zou Breakdown of academic impact, for papers by Sushmaa Chandralekha Selvakumar Breakdown of academic impact, for papers by Yuxiang Qiu Breakdown of academic impact, for papers by Yuting Kuang Breakdown of academic impact, for papers by Francesca Maria Orlandella Breakdown of academic impact, for papers by Cecilia Bica Breakdown of academic impact, for papers by Xianling Feng
Rankless by CCL
2026